Shlomo Segev
-
- Heart Rate Variability and Autonomic Control 8
- Cardiovascular Function and Risk Factors 5
- Nephrology top 5%
-
- Cardiovascular and exercise physiology 11
- Molecular Medicine top 5%
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 10
-
- Lipoproteins and Cardiovascular Health 6
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
-
- Cardiac Imaging and Diagnostics 5
-
- Glaucoma and retinal disorders 5
Shlomo Segev
92 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 151
- Cardiology and Cardiovascular Medicine 519
- Nephrology 144
- Complementary and alternative medicine 161
- Molecular Medicine 94
- Pharmacology 268
Countries citing papers authored by Shlomo Segev
This map shows the geographic impact of Shlomo Segev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shlomo Segev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shlomo Segev more than expected).
Fields of papers citing papers by Shlomo Segev
This network shows the impact of papers produced by Shlomo Segev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shlomo Segev. The network helps show where Shlomo Segev may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shlomo Segev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 0 | |
| 5 | 2020 | 20 | |
| 6 | 2020 | 3 | |
| 7 | 2020 | 4 | |
| 8 | 2016 | 40 | |
| 9 | 2013 | 16 | |
| 10 | 2012 | 19 | |
| 11 | 2012 | 66 | |
| 12 | 2011 | 24 | |
| 13 | 2006 | 65 | |
| 14 | 2003 | 20 | |
| 15 | 2003 | 82 | |
| 16 | 1999 | 42 | |
| 17 | 1996 | 37 | |
| 18 | The intravitreal penetration of orally administered ciprofloxacin in humans. | 1991 | 47 |
| 19 | 1990 | 7 | |
| 20 | 1990 | 7 |
About Shlomo Segev
Shlomo Segev is a scholar working on Applied Microbiology and Biotechnology, Complementary and alternative medicine and Cardiology and Cardiovascular Medicine, having authored 98 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cardiovascular and exercise physiology (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Heart Rate Variability and Autonomic Control (8 papers), Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Cardiac Imaging and Diagnostics (5 papers), Glaucoma and retinal disorders (5 papers) and Cardiovascular Function and Risk Factors (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (519 citations), Nephrology (144 citations) and Complementary and alternative medicine (161 citations). Shlomo Segev has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Shaye Kivity, Yechezkel Sidi, Elad Maor, Eitan Rubinstein, Ilan Goldenberg, Moshe Rehavi, Moshe Nussinovitch, Udi Nussinovitch, Naomi Nussinovitch and Keren Elishkevitz.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.